Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Krajewski

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Experimental Neurology|September 24, 2004
Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitationMaryla Krajewska, Robert E Rosenthal, Jowita Mikolajczyk, et al.
Cancer Cell|July 9, 2010
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumorsJianfei Qi, Koh Nakayama, Robert D Cardiff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instabilitySvetlana Baranovskaya, Yolanda Martin, Sergio Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Elevated expression of inhibitor of apoptosis proteins in prostate cancerMaryla Krajewska, Stan Krajewski, Steven Banares, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 18, 2009
Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sectionsMaryla Krajewska, Layton H Smith, Juan Rong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responsesGaëlle Le Negrate, Benjamin Faustin, Kate Welsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancerKaren Liby, Mara Rendi, Nanjoo Suh, et al.
Pigment Cell & Melanoma Research|May 20, 2011
Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathwaysYongmei Feng, Elisa Barile, Surya K De, et al.
Cancer Research|May 20, 2004
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancerMara H Rendi, Nanjoo Suh, William W Lamph, et al.
Cancer Research|April 15, 2010
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesisZhi Hong Lu, Mark B Shvartsman, Andrew Y Lee, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Experimental Neurology|September 24, 2004
Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitationMaryla Krajewska, Robert E Rosenthal, Jowita Mikolajczyk, et al.
Cancer Cell|July 9, 2010
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumorsJianfei Qi, Koh Nakayama, Robert D Cardiff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instabilitySvetlana Baranovskaya, Yolanda Martin, Sergio Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Elevated expression of inhibitor of apoptosis proteins in prostate cancerMaryla Krajewska, Stan Krajewski, Steven Banares, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 18, 2009
Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sectionsMaryla Krajewska, Layton H Smith, Juan Rong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responsesGaëlle Le Negrate, Benjamin Faustin, Kate Welsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancerKaren Liby, Mara Rendi, Nanjoo Suh, et al.
Pigment Cell & Melanoma Research|May 20, 2011
Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathwaysYongmei Feng, Elisa Barile, Surya K De, et al.
Cancer Research|May 20, 2004
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancerMara H Rendi, Nanjoo Suh, William W Lamph, et al.
Cancer Research|April 15, 2010
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesisZhi Hong Lu, Mark B Shvartsman, Andrew Y Lee, et al.
Pageof 7